or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    NBIX C Neurocrine Biosciences, Inc. -0.91
    ITCI C Intra-Cellular Therapies Inc. 2.42
    OMER D Omeros Corporation 1.20
    KROS D Keros Therapeutics, Inc. 1.21
    XGN D Exagen Inc. 1.56
    PHAT D Phathom Pharmaceuticals, Inc. -7.56
    FULC D Fulcrum Therapeutics, Inc. 2.61
    BAX F Baxter International Inc. 2.87
    OVID F Ovid Therapeutics Inc. 0.00
    IONS F Ionis Pharmaceuticals, Inc. 2.79
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Medicine Organ Systems Schizophrenia Alcohol Bone Cognitive Disorders Diabetes Disease Dystrophy Epilepsy Genodermatoses Hemoglobin Insomnia Movement Disorders Neurological Disorders Rare Diseases Syndromes Acid Acromegaly

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 10.1
    IBRN F iShares Neuroscience and Healthcare ETF 9.29
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 8.62
    FBT D First Trust Amex Biotech Index Fund 6.58
    BBP C BioShares Biotechnology Products Fund 5.71
    View all Disorders ETFs...
    Compare ETFs
    Compare FBT to BBP Compare PBE to BBP Compare SURI to FBT

        Disorders Stocks Recent News

        Date Stock Title
        May 31 IONS Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
        May 31 IONS Ionis hereditary angioedema therapy succeeds in late-stage trials
        May 31 IONS Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema
        May 30 BAX Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
        May 29 NBIX Neurocrine Biosciences to Participate at Investor Conferences in June
        May 29 BAX New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
        May 29 ITCI Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference
        May 29 BAX Reasons to Retain Baxter International (BAX) in Your Portfolio Now
        May 28 IONS Ionis: Tough Run For Share Price Belies Multiple Reasons For Optimism
        May 28 NBIX Neurocrine Biosciences CEO Gorman stepping down in October
        May 28 NBIX Neurocrine Biosciences Announces CEO Succession Plan
        May 28 NBIX Neurocrine Biosciences to Present New Phase 3 CAHtalyst™ Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024
        May 28 PHAT Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
        May 28 IONS Ionis to hold donidalorsen Phase 3 data webcast
        May 27 ITCI Hedge Funds Like Intra-Cellular Therapies (NASDAQ:ITCI)
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Biopharmaceutical Medicine Organ Systems Schizophrenia Alcohol Bone Cognitive Disorders Diabetes Disease Dystrophy Epilepsy Genodermatoses Hemoglobin Insomnia Movement Disorders Neurological Disorders Rare Diseases Syndromes Acid Acromegaly
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags